Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’ By: MarketWatch November 05, 2021 at 10:08 AM EDT Pfizer’s experimental COVID-19 antiviral pill can cut the risk of ending up in the hospital or dying by 89%. Read More >> Related Stocks: Atea Pharmaceuticals Inc Enanta Pharmaceutica Merck & Co Pfizer SPX
